Literature DB >> 6589021

Plasma and intracellular levels of lactate dehydrogenase, phosphohexose isomerase and lysozyme activity in acute leukemia.

A D Ho, W Fiehn, W Hunstein.   

Abstract

Plasma and intracellular levels of lactate dehydrogenase (LDH), phosphohexose isomerase (PHI) and lysozyme activities were investigated in 20 patients with acute myelocytic leukemia (AML), 18 patients with acute lymphatic leukemia (ALL) and 10 patients with chronic myelocytic leukemia in blast transformation (CML/BT). Though the plasma levels of LDH and PHI in all patients with acute leukemia were elevated as compared to control persons there was no distinctive pattern which could be of use in the classification of acute leukemia. On the other hand the intracellular levels of these enzymes could be of value in classifying acute leukemia. The leukemic lymphoblasts were characterized by low levels of PHI and lysozyme as compared to leukemic myeloblasts or to normal lymphocytes (p less than 0.01). The LDH/PHI ratio is also significantly higher in leukemic lymphoblasts than in leukemic myeloblasts or in normal lymphocytes (p always less than 0.01). These characteristics might also be made use of in identifying the blasts of CML/BT als "lymphoid" or "myeloid" in corresponding cases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6589021     DOI: 10.1007/bf00320380

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  23 in total

1.  Lysozyme in Haematology pathophysiology and clinical use.

Authors:  N E Hansen
Journal:  Scand J Haematol       Date:  1975-05

2.  A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE.

Authors:  D J PROCKOP; W D DAVIDSON
Journal:  N Engl J Med       Date:  1964-02-06       Impact factor: 91.245

3.  Blood enzymes in cancer and other diseases.

Authors:  O BODANSKY
Journal:  Adv Cancer Res       Date:  1961       Impact factor: 6.242

4.  Plasma lactic dehydrogenase and phosphohexose isomerase in leukemia.

Authors:  M C BLANCHAER; P T GREEN; J P MACLEAN; M J HOLLENBERG
Journal:  Blood       Date:  1958-03       Impact factor: 22.113

5.  The carbohydrate metabolism of leukocytes: a review.

Authors:  W S BECK; W N VALENTINE
Journal:  Cancer Res       Date:  1953 Apr-May       Impact factor: 12.701

6.  Human Ia alloantigens as cell-differentiation markers of normal and pathologic leukocyte surfaces.

Authors:  P Wernet; C Betsch; P Barth; S Jaramillo; F Schunter; H D Waller; K Wilms
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

Review 7.  Enzymes in cancer.

Authors:  M K Schwartz
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

8.  Impaired pentose phosphate shunt and decreased glycolytic activity in lymphocytes of chronic lymphocytic leukemia. Metabolic pathway.

Authors:  J I Brody; F A Oski; D E Singer
Journal:  Blood       Date:  1969-10       Impact factor: 22.113

9.  Carbohydrate metabolism in leukocytes. 13. Differentiation by metabolism of leukemic leukocytes into three groups.

Authors:  R L Stjernholm; N V Dimitrov; S Zito
Journal:  J Reticuloendothel Soc       Date:  1970-05

10.  The prognostic value of serum lysozyme activity in acute myelogenous leukemia.

Authors:  E Alsabti
Journal:  Med Pediatr Oncol       Date:  1979
View more
  2 in total

1.  Serum enzyme concentrations in untreated acute myeloid leukaemia.

Authors:  C S Scott; M Davey; A Hamilton; D R Norfolk
Journal:  Blut       Date:  1986-05

2.  Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia.

Authors:  Maro Ohanian; Uri Rozovski; Farhad Ravandi; Guillermo Garcia-Manero; Elias Jabbour; Hagop M Kantarjian; Zeev Estrov
Journal:  Br J Haematol       Date:  2014-11-21       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.